LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was downgraded by equities researchers at Barrington Research from an “outperform” rating to a “market perform” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. Wall Street Zen cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings lowered shares of LeMaitre Vascular from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 30th. Finally, Zacks Research downgraded LeMaitre Vascular from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Get LeMaitre Vascular alerts:Read Our Latest Analysis on LeMaitre VascularLeMaitre Vascular Price PerformanceShares of NASDAQ:LMAT opened at $105.78 on Wednesday.